HZHuaping Zhang

Huaping Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Huaping Zhang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Haixia Yu

    Translational Medicine Research Center Shanxi Medical University Taiyuan Shanxi PR China

    4 shared publications
  • Hui Zhou

    Translational Medicine Research Center Shanxi Medical University Taiyuan Shanxi PR China

    4 shared publications
  • Xuefen Pang

    National Key Disciplines, Key Laboratory for Cellular Physiology of Ministry of Education Shanxi Medical University Taiyuan Shanxi PR China

    4 shared publications
  • Zhenxiang Zhao

    Translational Medicine Research Center, Shanxi Medical University, Xinjiannanlu 56, Taiyuan, 030001, Shanxi, People's Republic of China

    3 shared publications
  • Jiahui Zhao

    Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

    2 shared publications
  • Jian Yang

    Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China

    2 shared publications

Latest Publications

  • Open Access

    Myocardium miRNA Analysis Reveals Potential Biomarkers of Sudden Coronary Death in Rats

    by Chunmei Zhao, Xinyu Zhou, Yaqin Bai, Zhenxiang Zhao, Huaping Zhang, Cairong Gao, Keming Yun, Xiangjie Guo

    This study aims to provide potential biomarkers and reveal the molecular mechanism of sudden coronary death (SCD). Rat models of atherosclerotic death (ASD), coronary atherosclerosis (AS), and acute myocardial ischemia (AMI) and sham groups were established via the gavage of high-fat emulsion and left coronary artery ligation. The myocardium was collected, and transcriptome sequencing was performed. Differentially expressed miRNAs (DEmiRNAs) were identified using edeR software. The target genes were predicted using TargetScan, and functional enrichment analysis was performed via KEGG. Then, an miRNA–mRNA interaction network was constructed using Cytoscape. The key miRNAs with biomarker potential were identified using LASSO regression. A total of 217, 224, and 86 DEmiRNAs were identified in the ASD, AS, and AMI groups compared with the sham group, respectively. The Ras and Rap1 pathways were mainly expressed in ASD. The β-alanine and sphingolipid metabolisms were expressed in AMI. Finally, miR-106b, miR-195, miR-33, miR-652, miR-466b, and miR-6321 were identified as biomarkers of ASD. MiR-205, miR-877, miR-325, and miR-344b were identified as biomarkers of AMI. miR542-Atg12 was involved in the RIG-I-like receptor signaling pathway, miR6328-Gstz1 was involved in tyrosine metabolism, and miR483-Dusp5 was involved in the MAPK signaling pathway. This study provides a reference for the identification of SCD in forensic pathology.


  • Genistein suppresses ox‐LDL‐elicited oxidative stress and senescence in HUVECs through the SIRT1‐p66shc‐Foxo3a pathways

    by Huaping Zhang, Xuefen Pang, Haixia Yu, Hui Zhou

    The anti‐senescence function of genistein is related to inhibiting oxidative stress, however, the mechanism has not been clarified. The present study aimed to explore the effects of genistein on oxidized low‐density lipoprotein (ox‐LDL)‐induced endothelial senescence and the role of the sirtuin‐1 (SIRT1)—66‐kDa Src homology 2 domain‐containing protein (p66Shc)–forkhead box protein O3 (Foxo3a) pathways in the process. In this paper, human umbilical vein endothelial cells were pretreated with 1000 nM genistein for 30 min and then incubated with 50 mg/L ox‐LDL for another 12 h; meanwhile, the functions of adenovirus‐mediated overexpression of p66shc and small interfering RNA‐mediated silencing of SIRT1 were investigated. Results showed that genistein pretreatment alleviated ox‐LDL‐induced mitochondrial reactive oxygen species, the levels of oxidatively modified DNA (8‐OHdG) and pai‐1, and the activity of SA‐β‐gal, which was associated with mitigating p66shc. Further studies indicated the inhibitory effect of genistein on p66shc was correlated with suppressing the acetylation and phosphorylation of p66shc, and ameliorating its mitochondrial translocation by activating SIRT1. Moreover, the inactivated p66shc could enhance the activity of Foxo3a via restraining the phosphorylation and triggering nucleus accumulation. The study demonstrates genistein could prevent ox‐LDL‐induced mitochondrial oxidative stress and senescence through the SIRT1–p66shc–Foxo3a pathways.


  • Genistein protects against ox-LDL-induced senescence through enhancing SIRT1/LKB1/AMPK-mediated autophagy flux in HUVECs

    by Huaping Zhang, Xiaorong Yang, Xuefen Pang, Zhenxiang Zhao, Haixia Yu, Hui Zhou

    The anti-senescence activity of genistein is associated with inducing autophagy; however, the underlying mechanisms are not fully understood. In this study, human umbilical vein endothelial cells (HUVECs) were pretreated with genistein (1000 nM) for 30 min and then exposed to ox-LDL (50 mg/L) for another 12 h. The study found that genistein inhibited the ox-LDL-induced senescence (reducing the levels of P16 and P21 protein, and the activity of SA-β-gal); meanwhile, the effect of genistein was bound up with enhancing autophagic flux (increasing LC3-II, and decreasing the level of P62, p-mTOR and p-P70S6K). Moreover, SIRT1/LKB1/AMPK pathway was involved in genistein accelerating autophagic flux and mitigating senescence in HUVECs. The present study illustrated that genistein was a promising therapeutic agent to delay aging process and extend longevity.


  • MiR-34a/sirtuin-1/foxo3a is involved in genistein protecting against ox-LDL-induced oxidative damage in HUVECs

    by Huaping Zhang, Zhenxiang Zhao, Xuefen Pang, Jian Yang, Haixia Yu, Yinhong Zhang, Hui Zhou, Jiahui Zhao


  • Genistein Protects Against Ox-LDL-Induced Inflammation Through MicroRNA-155/SOCS1-Mediated Repression of NF-ĸB Signaling Pathway in HUVECs

    by Huaping Zhang, Zhenxiang Zhao, Xuefen Pang, Jian Yang, Haixia Yu, Yinhong Zhang, Hui Zhou, Jiahui Zhao

    Genistein plays an important role in the prevention of atherosclerosis. However, the underlying mechanisms have not been fully investigated. In this study, human umbilical vein endothelial cells (HUVECs) were pretreated with genistein (10, 100, and 1000 nM) for 6 h and then exposed to ox-LDL (50 mg/L) for another 24 h. Results showed that ox-LDL induced the expressions of E-selectin, P-selectin, monocyte chemotactic protein-1, interleukin-8, vascular adhesion molecule-1, and intercellular adhesion molecule-1, which were counteracted by genistein. The inhibitory effect was further enhanced with the augment of genistein (10, 100, and 1000 nM). Further analyses demonstrated the effect of genistein was associated with reducing miR-155 and elevating SOCS1, and miR-155 mimics or SOCS1 siRNA acted similarly in genistein ameliorating inflammation. Moreover, the effect of genistein was accompanied with the inhibition of the NF-ĸB signaling pathway. The present study indicates that genistein could reverse ox-LDL-induced inflammation through miR-155/SOCS1-mediated repression of the NF-ĸB signaling pathway in HUVECs.